COMPARISON OF BILIRUBIN LEVELS WITH TWO INTRAVENOUS LIPID EMULSIONS IN PREMATURE INFANTS REQUIRING PARENTERAL NUTRITION
CP-084
USE OF INFLIXIMAB FOR STEROID-REFRACTORY GRAFT-VERSUS-HOST DISEASE
CP-083
PREVALENCE OF MALNUTRITION AND ASSOCIATED RISK FACTORS
CP-081
MANAGEMENT OF UNCONTROLLED BLOOD PRESSURE IN PATIENTS WITH MULTIPLE DRUG INTOLERANCE REFERRED TO A SPECIALIST HYPERTENSION CLINIC
CP-080
THROMBOPOIETIN RECEPTOR AGONIST TREATMENT IN IDIOPATHIC THROMBOCYTOPENIC PURPURA
CP-079
RELATIONSHIP BETWEEN ADHERENCE TO HEPATITIS C TREATMENT AND RAPID, EARLY AND SUSTAINED VIRAL RESPONSE
CP-078
OPTIMISING RESOURCES IN COMPOUNDING PREPARATIONS: SIMPLE MEASURES AIMED AT REDUCING COSTS
CP-077
ANALYSIS OF COSTS AND PRESCRIPTION GUIDELINES OF ETANERCEPT AND ADALIMUMAB IN PATIENTS OF RHEUMATOLOGY, DERMATOLOGY AND GASTROENTEROLOGY SERVICES ON THE PHARMACY OUTPATIENT UNIT
CP-076
POST-MARKETING ACTIVE PHARMACOVIGILANCE IN A CENTRAL HOSPITAL
CP-075
NATALIZUMAB: EFFECTIVENESS AND SAFETY IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS IN A TERTIARY HOSPITAL.
CP-074
INTERVENTIONS TO IMPROVE MEDICINES ADHERENCE IN PATIENTS WITH SEVERAL CHRONIC CONDITIONS: AN OVERVIEW OF SYSTEMATIC REVIEWS
CP-073
OPTIMIZING INFLIXIMAB TREATMENT IN INFLAMMATORY BOWEL DISEASE
CP-072
GOOD PRACTICE IN COMPLEX PARENTERAL IRON REGIMENS: A SURVEY IN 5 SURGICAL DEPARTMENTS
CP-069
QUALITY OF ANTIBIOTIC TREATMENT IN PRETERM NEONATES: A READY-TO-USE FORMULATION OF GENTAMICIN SULPHATE
CP-068
COMPATIBILITY ANALYSIS OF PROPOFOL - OPTIMIZATION OF DRUG TREATMENT SAFETY
